For years, cell biologists have relied on classic growth media, like Dulbecco Modified Eagle's Medium (DMEM), MCDB-105 and RPMI 1640. With scores of publications to their names, these time-proven standbys continue to form a sound foundation for in vitro culture experiments.
Add supplements such as fetal bovine serum, growth factors, trace elements, and /or antibiotics, depending on cell type. The media are buffered and sterile filtered, and tested to stringent quality standards.
Need help choosing? See our Media Selection Guide
|Dulbecco's Modified Eagle's Medium: 1X DMEM, 4.25g/L Glucose||Size: 500 ml||CAT.#: 180-500||Price: $25.63|
|MCDB 105 Medium, unmodified: Unmodified MCDB 105 Medium||Size: 500 ml||CAT.#: 117-500||Price: $48.43|
|RPMI 1640 Medium, w/L-Glutamine: RPMI 1640 Medium, with L-Glutamine, without HEPES||Size: 500 ml||CAT.#: 185-500||Price: $26.65|
|L-Glutamine: Amino acid supplement for cell culture media, important for cell growth & function||Size: 100 ml||CAT.#: 013-100||Price: $33.00|
Liao, Y., Y. Deng, J. Liu, Z. Ye, Z. You, S. Yao and S. He. 2017. MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression. Gynecologic Oncology, 143:655-663.
Muranen, T., M.Iwanicki, N. Curry, J. Hwang, C. DuBois,J. Coloff, D. Hitchcock, C. Clish, J. Brugge and N. Kalaany. 2017. Starved epithelial cells uptake extracellular matrix for survival. Nature Commumicatins, 8: doi:10.1038/ncomms13989.
Guo, T., G. Shen, X. Tong, G. Zhou, Y. Wan, D. Li, X. Dai, X. Sun and Y. Tian. 2016. miR-125b expression in ovarian cancer cell lines. Int J Clin Exp Pathathol, 9:5267-5275.
Liao, Y., Y. Deng, J. Liu, Z. Ye, Z. You, S. Yao and S. He. 2016. MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression. Gynecologic Oncology, 143:655-663.
Wu, B., S. Shrestha, K. Ong, D. Johns, L. Dunn, L. Hou, P. Barter and K. Rye. 2015. Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis. Intl J Cardiol, 199:204-212.
Zhu, Z., L. Song, J. He, Y. Sun, X. Liu and X. Zou. 2015. Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer. Int J Clin Exp Pathol, 8:10082-10091.
Davidowitz, R., L. Selfors, M. Iwanicki, K. Elias, A. Karst, H. Piao, T. Ince, M. Drage, J. Dering, G. Konecny, U. Matulonis, G. Mills, D. Slamon, R. Drapkin and J. Brugge. 2014. Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. J Clin Invest, 124:2611–2625.
Stein, J., C. Iwuchukwu, K. Maier and V. Gahtan. 2014. Thrombospondin-1−induced vascular smooth muscle cell migration and proliferation are functionally dependent on microRNA-21. Surgery, 155:228-233.
Meng, E., B. Long, P. Sullivan, S. McClellan, M. Finan, E. Reed, L. Shevde, and R. Rocconi. 2012. CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival. Clin & Exp Met, 29:939-948.
Moffett, J., L.M. Fray, and N.J. Kubat. 2012. Activation of endogenous opioid gene expression in human keratinocytes and fibroblasts by pulsed radiofrequency energy fields. Journal of pain research. 5:347.
Iwanicki, M., R. Davidowitz, M. Ng, A. Besser, T. Muranen, M. Merritt, G. Danuser, T. Ince, and J. Brugge. 2011. Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium. Cancer Discovery, 1:144.
Ray, A., E. Meng, E. Reed, L. Shevde, andn R. Rocconi. 2011. Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells. Intl J Oncol, 39:797-804.
Konecny, G., R. Glas, J. Dering, K. Manivong, J. Qi, R. Finn, G. Yang, K. Hong, C. Ginther, B. Winterhoff, G. Gao, J. Brugge, and D. Slamon. 2009. Activity of the multikinase inhibitor dasatinib against ovarian cancer cells. British J Cancer, 101:1699-1708